Extra ordinary General Meeting of the members of the Company is scheduled to be held on 20th day of January, 2026 to transact the business as per Notice attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Raaj Medisafe India has called an Extraordinary General Meeting on January 20, 2026, to seek shareholder approval for three key items. First, to increase authorized share capital from Rs. 15 crore to Rs. 18 crore by creating 30 lakh additional equity shares of Rs. 10 each. Second, to issue 32.75 lakh equity shares on a preferential basis to 17 non-promoter allottees at Rs. 55 per share (including Rs. 45 premium), raising approximately Rs. 18.01 crore. The funds will be used to acquire plant, machinery, and the liquor caps business of Fabrizo Industries' Goa unit, expand manufacturing capacity at the Pithampur (Madhya Pradesh) hygiene products facilities, and meet working capital needs. Third, to seek approval under Section 185 to give loans, guarantees, or security up to Rs. 20 crore to subsidiaries, associates, or group entities. There will be no change in management or control, though promoter holding will dilute from 73.80% to 59.08% post-issue.
Existing shareholders will see their stake diluted by about 19.94% as new shares are issued to non-promoters. The capital raise is aimed at funding a specific acquisition and capacity expansion, which could support future growth if the acquired assets perform well, but it also signals the company needs external funding for these initiatives.